ChemoMetec A/S · MUN:CHY

ChemoMetec A/S financial statements

ChemoMetec A/S's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in DKK

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue511.1M495.6M407.4M444.4M428.4M281.1M214.1M175.5M112.7M90.3M
Cost of revenue25.1M30.1M40.3M49.0M44.1M27.8M20.2M16.9M13.2M10.1M
Gross profit486.0M465.5M367.6M395.4M384.3M253.3M193.9M158.6M99.5M80.2M
Research and development15.4M10.4M8.39M7.16M7.23M6.49M6.48M5.69M3.69M3.80M
Selling, general and administrative41.3M23.4M25.7M24.1M20.3M20.2M
Operating income251.0M236.5M169.0M228.5M201.5M116.0M77.5M54.1M24.3M10.4M
Depreciation and amortization30.3M21.5M17.2M20.4M20.0M19.6M15.1M10.8M5.79M5.45M
EBITDA281.3M258.0M186.2M248.9M221.6M135.6M92.6M64.9M30.1M15.9M
Interest expense392.0K17.4M1.28M1.09M1.52M918.0K1.19M716.0K887.0K1.07M
Income before tax258.2M225.0M176.6M230.4M203.2M112.7M75.9M53.7M23.3M8.65M
Income tax56.3M50.3M40.3M51.7M43.8M24.4M16.8M11.9M5.09M1.17M
Net income201.8M174.7M136.3M178.7M159.5M88.4M59.2M41.8M18.2M7.49M
Earnings per share, basic11,600.0010,040.007.8310.279.165.083.512.691.170.48
Earnings per share, diluted11,600.0010,040.007.83

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents290.2M341.8M296.1M316.6M209.0M150.1M96.9M98.2M9.78M12.4M
Short-term investments3.39M-93.8M-82.6M
Receivables99.2M79.6M69.1M59.7M65.9M62.6M44.3M36.0M19.6M14.7M
Inventory126.2M120.8M119.5M112.6M66.8M30.1M25.1M19.5M16.8M13.3M
Current assets524.8M554.6M489.8M492.7M352.9M244.4M168.3M154.8M46.8M41.0M
Property, plant and equipment126.6M115.6M92.0M82.7M74.8M42.5M43.4M38.1M28.9M26.4M
Goodwill7.36M7.35M0
Total assets860.9M839.5M676.7M658.0M501.3M344.9M263.1M238.2M114.0M97.6M
Accounts payable38.1M16.1M11.1M17.6M17.0M8.71M8.43M9.71M7.26M4.89M
Current liabilities128.2M143.7M98.5M119.2M137.4M72.0M47.7M55.0M17.9M21.1M
Long-term debt017.8M10.9M
Total debt4.59M6.40M4.16M7.16M6.79M2.36M2.29M18.8M20.1M22.1M
Total liabilities135.5M151.4M111.4M124.9M144.1M79.9M60.4M64.9M41.0M33.2M
Shareholders' equity725.4M688.1M565.3M533.0M357.2M265.0M202.8M173.3M73.0M64.4M
Shares outstanding17.4M17.4M17.4M17.4M17.4M17.4M16.9M15.6M15.5M15.7M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations210.4M207.4M129.0M154.1M176.9M107.9M72.0M58.3M25.4M9.76M
Capital spending-28.3M-29.9M-20.9M-40.8M-55.9M-24.6M-26.7M-27.1M-16.5M-10.6M
Free cash flow182.0M177.6M108.1M113.3M120.9M83.3M45.3M31.2M8.97M-833.0K
Cash from investing-99.8M-85.5M-43.5M-40.8M-56.0M-24.7M-26.6M-27.1M-16.5M-10.3M
Cash from financing-161.6M-75.0M-105.7M-2.92M-69.0M-26.0M-46.3M57.8M-7.93M-355.0K
Dividends paid-121.8M-69.6M-104.4M-69.6M-26.1M-348.1M-136.0M-136.0M-136.0M
Share buybacks-38.6M1.87M-9.57M
Change in cash-51.0M47.0M-20.2M107.5M58.9M53.2M-1.25M89.0M933.0K-1.70M